0 results available. Select is focused ,type to refine list, press Down to open the menu,
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, ...
The following section summarizes insights on Evofem Biosciences Inc's EV / IC Growth Ratio:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EV / IC Growth Ratio in the valuation category include:
A heuristic used to measure the level of revenue growth relative to the EV / Invested Capital multiple.
The chart above depicts the distribution of ev / ic growth ratio for companies operating in the Healthcare sector in the Developed economic region. Over 1,390 companies were considered in this analysis, and 1,342 had meaningful values. The average ev / ic growth ratio of companies in the sector is 0.2 with a standard deviation of 0.3.
Evofem Biosciences Inc's EV / IC Growth Ratio of 0.0 ranks in the 4.7% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,398 |
| Included Constituents | 1,342 |
| Min | -0.3 |
| Max | 2.8 |
| Median | 0.1 |
| Mean | 0.2 |
| Standard Deviation | 0.3 |
You can find companies with similar ev / ic growth ratio using this stock screener.